We are live on ! Find out more
BBOT

BridgeBio Oncology
BBOT

42 hedge funds and large institutions have $658M invested in BridgeBio Oncology in 2025 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding in top 10

Funds holding in top 10: 1 → 4 (+3)

270% more capital invested

Capital invested by funds: $178M → $658M (+$480M)

50% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 16

43% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 7

24% more funds holding

Funds holding: 34 → 42 (+8)

16.67% less ownership

Funds ownership: 88.41% → 71.74% (-17%)

Holders
42
Holders Change
+8
Holders Change %
+23.53%
% of All Funds
0.55%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.05%
New
24
Increased
10
Reduced
7
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$156M
2
DM
Deerfield Management
New York
+$50.9M
3
OFM
Omega Fund Management
Massachusetts
+$34.3M
4
AI
Alphabet Inc
California
+$29.4M
5
EC
EcoR1 Capital
California
+$29.4M

Top Sellers

Rank Fund Capital Flow
1
SC
Sculptor Capital
New York
-$8.5M
2
FCM
Farallon Capital Management
California
-$6.39M
3
HCI
Harraden Circle Investments
New York
-$6.05M
4
Millennium Management
Millennium Management
New York
-$5.5M
5
WRBC
W.R. Berkley Corp
Connecticut
-$4.73M
Name Holding Trade Value Shares
Change 		Change in
Stake
IC
26
Ikarian Capital
Texas
$2.84M +$2.55M +245,231 New
SC
27
Stempoint Capital
New York
$2.16M -$1.35M -129,198 -41%
State Street
28
State Street
Massachusetts
$2.05M +$1.84M +176,695 New
Fidelity Investments
29
Fidelity Investments
Massachusetts
$1.88M +$1.69M +162,077 New
SCM
30
Sio Capital Management
New York
$1.51M +$1.36M +130,628 New
TD Asset Management
31
TD Asset Management
Ontario, Canada
$1.51M -$153K -14,710 -10%
WP
32
Woodline Partners
California
$1.2M +$4.79K +460 +0.4%
MCM
33
Moore Capital Management
New York
$1.16M – – –
BFM
34
Boothbay Fund Management
New York
$1.12M +$1.01M +96,551 New
Northern Trust
35
Northern Trust
Illinois
$1.11M +$1,000K +95,957 New
UBS Group
36
UBS Group
Switzerland
$605K -$170K -16,308 -24%
XT
37
XTX Topco
Cayman Islands
$271K +$244K +23,384 New
CUAMC
38
China Universal Asset Management Company
China
$57.9K +$52.1K +5,000 New
Bank of America
39
Bank of America
North Carolina
$15.4K +$13.8K +1,329 New
Morgan Stanley
40
Morgan Stanley
New York
$9.97K +$8.97K +861 New
FIA
41
FNY Investment Advisers
New York
$1K -$282K -27,084 -100%
SC
42
Sculptor Capital
New York
– -$8.5M -800,000 Closed
FCM
43
Farallon Capital Management
California
– -$6.39M -600,000 Closed
HCI
44
Harraden Circle Investments
New York
– -$6.05M -569,831 Closed
WRBC
45
W.R. Berkley Corp
Connecticut
– -$4.73M -445,195 Closed
Toronto Dominion Bank
46
Toronto Dominion Bank
Ontario, Canada
– -$4.72M -444,377 Closed
PA
47
Perceptive Advisors
New York
– -$4.23M -398,000 Closed
DAM
48
Decagon Asset Management
United Kingdom
– -$3.7M -348,223 Closed
SCM
49
Shaolin Capital Management
Florida
– -$3.1M -292,338 Closed
JP Morgan Chase
50
JP Morgan Chase
New York
– -$2.24M -210,125 Closed
1
2
3

BBOT Hedge Fund Activity: Q3 2025 in Review

42 of the 7,631 institutional investors tracked by Wall St. Rank reported a position in BridgeBio Oncology (BBOT) for Q3 2025, worth a combined $658M — up 270% from $178M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new BBOT positions and 16 closed out — a net gain of 8 holders — while 10 added to existing stakes and 7 trimmed.

The largest buyer was Cormorant Asset Management, adding an estimated $156M. The largest seller was Sculptor Capital, exiting entirely with an estimated $8.5M sold.

  • 42 institutional investors held BridgeBio Oncology (BBOT) as of Q3 2025, up from 34 in Q2 2025.
  • Funds reported $658M of BridgeBio Oncology stock for Q3 2025, up 270% quarter-over-quarter.
  • 24 funds opened new BridgeBio Oncology positions in Q3 2025 and 16 closed out, a net change of +8 holders.
  • The largest BridgeBio Oncology buyer in Q3 2025 was Cormorant Asset Management, an estimated $156M added.
  • The largest BridgeBio Oncology seller in Q3 2025 was Sculptor Capital, an estimated $8.5M sold.

Based on aggregated 13F filings for Q3 2025.